FDA NDC Directory · JSON-LD · Markdown

LENMELDY

NDC 83222-0200 · CELLULAR THERAPY · SUSPENSION

Generic nameatidarsagene autotemcel
Labeler / ManufacturerOrchard Therapeutics (Europe) Ltd
Marketing categoryBiologic License Application · App BLA125758
Dosage form / routeSUSPENSION · INTRAVENOUS
Active ingredientsATIDARSAGENE AUTOTEMCEL (11800000 1/1)
Marketing started20240426
Package count1

External sources

Source: openFDA. Public-domain (CC0).